Drug Discovery

In-Vitro Biological Testing

Bringing a new drug from concept to clinic requires seamless integration of scientific innovation and regulatory strategy. At MED Institute, we partner with clients at every stage of drug discovery, providing expertise in target validation, lead optimization, and pre-clinical development. Our team is adept at designing and executing studies that generate the robust data needed for regulatory submissions and risk assessments. We also offer guidance on regulatory strategy, helping you navigate IND submissions and early interactions with the FDA. By leveraging our drug discovery services, clients can accelerate their development timelines and improve the probability of regulatory and commercial success.

Our services include:

• Custom cell line/assay development
• Target identification and validation
• Hit identification through high-throughput screening
• Lead compound optimization
• Computational modeling and virtual screening